Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
dextroamphetamine alpha adrenergic receptor small molecule NA drugbank Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
NA approved,illicit inhibitor,inducer
dextroamphetamine alpha adrenergic receptor small molecule NA drugbank Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
NA approved,illicit inhibitor,inducer
dextroamphetamine alpha-1b adrenergic receptor small molecule NA drugbank Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
NA approved,illicit antagonist
dextroamphetamine alpha adrenergic receptor small molecule NA drugbank Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
NA approved,illicit inhibitor,inducer
dextroamphetamine alpha adrenergic receptor small molecule NA drugbank Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
NA approved,illicit inhibitor,inducer
dextroamphetamine alpha adrenergic receptor small molecule NA drugbank Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
NA approved,illicit inhibitor,inducer
dextroamphetamine alpha adrenergic receptor small molecule NA drugbank Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
NA approved,illicit inhibitor,inducer
dextroamphetamine synaptic vesicular amine transporter small molecule NA drugbank , DGIDB Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
2.12 approved,illicit inducer
dextroamphetamine synaptic vesicular amine transporter small molecule NA drugbank , DGIDB Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
2.12 approved,illicit inducer,inhibitor
dextroamphetamine sodium-dependent noradrenaline transporter small molecule NA drugbank , DGIDB Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
1.08 approved,illicit negative modulator
dextroamphetamine sodium-dependent dopamine transporter small molecule NA drugbank , DGIDB Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
1.24 approved,illicit negative modulator
dextroamphetamine trace amine-associated receptor-1 NA Successful target TTD , DGIDB Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
2.48 approved unknown
dextroamphetamine trace amine-associated receptor 1 small molecule NA drugbank , DGIDB Attention deficit hyperactivity disorder[MeSHID:D001289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Narcolepsy[MeSHID:D009290]
2.48 approved,illicit agonist
click here to return to the previous page